Findings from a postmarketing observational study showed an increased risk of GBS during the 42 days following vaccination.

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

Adverse events were frequent, and most were gastrointestinal-related, including nausea, vomiting, diarrhea, constipation.

Posdinemab works by targeting and neutralizing Alzheimer disease-specific phosphorylated tau, preventing its spread to other neurons.

HealthDay News — Doxycycline postexposure prophylaxis (doxyPEP) initiation is associated with decreases in sexually transmitted infections (STIs), according to a study published online January 6 in ...

Topline data were announced from the AUDACITY trial evaluating the Allurion Gastric Balloon, a swallowable, procedureless intragastric balloon, in adults with obesity.

Denosumab has greater preventive effect on fractures, but increased risk for MACE compared with oral bisphosphonates.

HealthDay News — For immunocompromised individuals, antibody response to respiratory syncytial virus (RSV) vaccines is heterogeneous and about 40% do not seroconvert, according to a research letter ...

The OraQuick HIV Self-Test is an in-vitro diagnostic home-use antibody test that utilizes oral fluid to determine whether a patient has been exposed to HIV.

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to GSK5764227 (GSK’227) for the treatment of adult patients with relapsed or refractory (R/R) osteosarcoma who have ...

While vaccination is the best way to protect against whooping cough, vaccination rates in children have fallen ...

An expert panel consisting of dietitians, doctors, nutritional epidemiologists, chefs, and weight loss researchers examined ...